Showing results (1241-1250 of 1,354) with videos related to
Sort By:
Pageof 136
Diabetologia|January 25, 2020
Glucose-dependent insulinotropic peptide and risk of cardiovascular events and mortality: a prospective studyAmra Jujić, Naeimeh Atabaki-Pasdar, Peter M Nilsson, et al.Journal of Hypertension|April 14, 2018
Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part B: obesity-induced cardiovascular disease, early prevention strategies and future research directionsVasilios Kotsis, Konstantinos Tsioufis, Christina Antza, et al.Cell Death & Disease|February 8, 2020
Correction: A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanomaBerglind O Einarsdottir, Joakim Karlsson, Elin M V Söderberg, et al.Acta Ophthalmologica|June 25, 2021
Perinatal famine is associated with excess risk of proliferative retinopathy in patients with type 2 diabetesOlena Fedotkina, Andrea Luk, Ruchi Jain, et al.The Journal of Clinical Investigation|September 17, 2024
Pericyte phenotype switching alleviates immunosuppression and sensitizes vascularized tumors to immunotherapy in preclinical modelsZhi-Jie Li, Bo He, Alice Domenichini, et al.Molecular Oncology|March 23, 2026
KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancerJennie N Jeyapalan, Veronika M Metzler, Simone de Brot, et al.Cell Death & Disease|July 26, 2018
A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanomaBerglind O Einarsdottir, Joakim Karlsson, Elin M V Söderberg, et al.Diabetes Research and Clinical Practice|March 8, 2024
International Diabetes Federation Position Statement on the 1-hour post-load plasma glucose for the diagnosis of intermediate hyperglycaemia and type 2 diabetesMichael Bergman, Melania Manco, Ilhan Satman, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 2023
Oncological outcomes of standard versus prolonged time to surgery after neoadjuvant chemoradiotherapy for oesophageal cancer in the multicentre, randomised, controlled NeoRes II trialK Nilsson, F Klevebro, B Sunde, et al.The Journal of Clinical Endocrinology and Metabolism|November 8, 2025
HMGCR and rosuvastatin regulates GLP-1 secretion and expression - a translational studyMichael G Miskelly, Andreas Lindqvist, Amra Jujić, et al.Pageof 136